Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin and prostaglandins: some recent developments

M J Smith

    Agents and Actions
    |June 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Aspirin's anti-inflammatory effects stem from inhibiting prostaglandin synthesis. This review examines experiments validating this key mechanism for aspirin's therapeutic actions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1.

    Blood·1998
    Same author

    An equation to QA check the total treatment time for single-catheter HDR brachytherapy.

    International journal of radiation oncology, biology, physics·1998
    Same author

    Inhibition of thromboxane synthesis attenuates insulin hypertension in rats.

    American journal of hypertension·1997
    Same author

    The effect of blockade of kappa-opioid receptors in the medial preoptic area on the luteinizing hormone surge in the proestrous rat.

    Brain research·1997
    Same author

    Significance of WBC differential when leukopenia is induced by 6-MP for IBD.

    Gastroenterology·1997
    Same author

    Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.

    Diabetes·1997
    Same journal

    Classification and biological distribution of histamine receptor sub-types. 1975.

    Agents and actions·1994
    Same journal

    Metiamide--an orally active histamine H2-receptor antagonist. 1973.

    Agents and actions·1994
    Same journal

    A brief survey of the history of inflammation. 1978.

    Agents and actions·1994
    Same journal

    The discovery of librium. 1972.

    Agents and actions·1994
    Same journal

    Notes and documents concerning the discovery of LSD. 1970.

    Agents and actions·1994
    Same journal

    Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

    Agents and actions·1994
    See all related articles

    Area of Science:

    • Pharmacology
    • Biochemistry

    Background:

    • Aspirin is a widely used nonsteroidal anti-inflammatory drug (NSAID).
    • Its anti-inflammatory and anti-rheumatic properties are well-established.
    • The underlying molecular mechanisms have been a subject of extensive research.

    Purpose of the Study:

    • To review experimental evidence supporting the hypothesis that aspirin's therapeutic effects are mediated by prostaglandin synthetase inhibition.
    • To consolidate findings on the role of prostaglandins in inflammation and rheumatic diseases.

    Main Methods:

    • Review of published experimental studies.
    • Analysis of data on prostaglandin levels and enzyme activity in relation to aspirin administration.
    • Examination of in vitro and in vivo experimental models.

    Related Experiment Videos

    Main Results:

    • Experimental data consistently demonstrate that aspirin inhibits prostaglandin synthetase activity.
    • This inhibition leads to reduced prostaglandin production.
    • The reduction in prostaglandins correlates with observed anti-inflammatory and anti-rheumatic effects.

    Conclusions:

    • The inhibition of prostaglandin synthetase is a primary mechanism for aspirin's anti-inflammatory and anti-rheumatic actions.
    • This finding validates the hypothesis and clarifies aspirin's therapeutic role.
    • Further research can build upon this understanding for novel drug development.